Fresenius Kabi Sets up Joint Venture With Bio-Techne, Wilson Wolf

Date : 01/21/2020 @ 2:24PM
Source : Dow Jones News
Stock : Fresenius SE and Company KGaA (QX) (FSNUY)
Quote : 11.7  -0.3 (-2.50%) @ 9:59PM

Fresenius Kabi Sets up Joint Venture With Bio-Techne, Wilson Wolf

Fresenius SE and Company... (QX) (USOTC:FSNUY)
Historical Stock Chart

2 Months : From Dec 2019 to Feb 2020

Click Here for more Fresenius SE and Company... (QX) Charts.
   By Kim Richters 
 

Fresenius SE & Co. (FRE.XE) said Tuesday that its subsidiary Fresenius Kabi has formed a joint venture with pharma peers Bio-Techne Corp. (TECH) and Wilson Wolf.

The collaboration will focus on providing technology to develop and commercialize cell and gene therapies, German health-care company Fresenius said of its medicines division's venture.

The company didn't disclose any financial details of the joint venture, which is equally owned by the three parties.

 

Write to Kim Richters at kim.richters@wsj.com

 

(END) Dow Jones Newswires

January 21, 2020 09:09 ET (14:09 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Latest FSNUY Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.